nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethacrynic acid—GSTA2—breast cancer	0.609	0.875	CbGaD
Ethacrynic acid—ALB—breast cancer	0.0871	0.125	CbGaD
Ethacrynic acid—ALB—Irinotecan—breast cancer	0.00698	0.322	CbGbCtD
Ethacrynic acid—ALB—Fluorouracil—breast cancer	0.0067	0.309	CbGbCtD
Ethacrynic acid—SLC22A6—Methotrexate—breast cancer	0.00433	0.2	CbGbCtD
Ethacrynic acid—ALB—Methotrexate—breast cancer	0.00369	0.17	CbGbCtD
Ethacrynic acid—GSTA2—embryo—breast cancer	0.00216	0.0785	CbGeAlD
Ethacrynic acid—GSTA2—epithelium—breast cancer	0.00176	0.064	CbGeAlD
Ethacrynic acid—ALB—mammary gland—breast cancer	0.00174	0.0632	CbGeAlD
Ethacrynic acid—ATP1A1—mammary gland—breast cancer	0.00168	0.0609	CbGeAlD
Ethacrynic acid—SLC12A1—epithelium—breast cancer	0.0016	0.0583	CbGeAlD
Ethacrynic acid—GSTA2—uterus—breast cancer	0.00146	0.0529	CbGeAlD
Ethacrynic acid—ATP1A1—nipple—breast cancer	0.00139	0.0504	CbGeAlD
Ethacrynic acid—GSTA2—female reproductive system—breast cancer	0.00131	0.0476	CbGeAlD
Ethacrynic acid—GSTA2—adrenal gland—breast cancer	0.00128	0.0464	CbGeAlD
Ethacrynic acid—GSTA2—female gonad—breast cancer	0.00119	0.0433	CbGeAlD
Ethacrynic acid—ATP1A1—embryo—breast cancer	0.00114	0.0416	CbGeAlD
Ethacrynic acid—GSTA2—endocrine gland—breast cancer	0.00111	0.0403	CbGeAlD
Ethacrynic acid—ATP1A1—epithelium—breast cancer	0.000934	0.0339	CbGeAlD
Ethacrynic acid—ATP1A1—skin of body—breast cancer	0.000888	0.0322	CbGeAlD
Ethacrynic acid—ATP1A1—endometrium—breast cancer	0.000837	0.0304	CbGeAlD
Ethacrynic acid—ATP1A1—uterus—breast cancer	0.000772	0.028	CbGeAlD
Ethacrynic acid—ATP1A1—pituitary gland—breast cancer	0.000758	0.0275	CbGeAlD
Ethacrynic acid—ATP1A1—adipose tissue—breast cancer	0.000755	0.0274	CbGeAlD
Ethacrynic acid—ALB—adrenal gland—breast cancer	0.000703	0.0255	CbGeAlD
Ethacrynic acid—ATP1A1—female reproductive system—breast cancer	0.000694	0.0252	CbGeAlD
Ethacrynic acid—ATP1A1—adrenal gland—breast cancer	0.000677	0.0246	CbGeAlD
Ethacrynic acid—ATP1A1—bone marrow—breast cancer	0.000655	0.0238	CbGeAlD
Ethacrynic acid—ATP1A1—female gonad—breast cancer	0.000631	0.0229	CbGeAlD
Ethacrynic acid—ATP1A1—endocrine gland—breast cancer	0.000587	0.0213	CbGeAlD
Ethacrynic acid—ALB—lymph node—breast cancer	0.000421	0.0153	CbGeAlD
Ethacrynic acid—ATP1A1—lymph node—breast cancer	0.000406	0.0147	CbGeAlD
Ethacrynic acid—Thrombocytopenia—Mitoxantrone—breast cancer	0.000192	0.00125	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Irinotecan—breast cancer	0.000192	0.00125	CcSEcCtD
Ethacrynic acid—Hypoglycaemia—Epirubicin—breast cancer	0.00019	0.00124	CcSEcCtD
Ethacrynic acid—Asthenia—Goserelin—breast cancer	0.00019	0.00124	CcSEcCtD
Ethacrynic acid—Diarrhoea—Tamoxifen—breast cancer	0.00019	0.00124	CcSEcCtD
Ethacrynic acid—Confusional state—Fluorouracil—breast cancer	0.000189	0.00123	CcSEcCtD
Ethacrynic acid—Body temperature increased—Vinorelbine—breast cancer	0.000188	0.00122	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Thiotepa—breast cancer	0.000187	0.00122	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Gemcitabine—breast cancer	0.000187	0.00122	CcSEcCtD
Ethacrynic acid—Anorexia—Mitoxantrone—breast cancer	0.000186	0.00122	CcSEcCtD
Ethacrynic acid—Anorexia—Irinotecan—breast cancer	0.000186	0.00122	CcSEcCtD
Ethacrynic acid—Diarrhoea—Melphalan—breast cancer	0.000186	0.00121	CcSEcCtD
Ethacrynic acid—Gastrointestinal haemorrhage—Epirubicin—breast cancer	0.000186	0.00121	CcSEcCtD
Ethacrynic acid—Nausea—Chlorambucil—breast cancer	0.000185	0.00121	CcSEcCtD
Ethacrynic acid—Vision blurred—Paclitaxel—breast cancer	0.000184	0.0012	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Fluorouracil—breast cancer	0.000183	0.0012	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Methotrexate—breast cancer	0.000183	0.00119	CcSEcCtD
Ethacrynic acid—Anorexia—Gemcitabine—breast cancer	0.000182	0.00118	CcSEcCtD
Ethacrynic acid—Vomiting—Vinblastine—breast cancer	0.000181	0.00118	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Paclitaxel—breast cancer	0.000181	0.00118	CcSEcCtD
Ethacrynic acid—Diarrhoea—Goserelin—breast cancer	0.000181	0.00118	CcSEcCtD
Ethacrynic acid—Body temperature increased—Thiotepa—breast cancer	0.000179	0.00117	CcSEcCtD
Ethacrynic acid—Headache—Vinblastine—breast cancer	0.000179	0.00117	CcSEcCtD
Ethacrynic acid—Anorexia—Fluorouracil—breast cancer	0.000179	0.00117	CcSEcCtD
Ethacrynic acid—Vomiting—Tamoxifen—breast cancer	0.000176	0.00115	CcSEcCtD
Ethacrynic acid—Malaise—Paclitaxel—breast cancer	0.000176	0.00115	CcSEcCtD
Ethacrynic acid—Hypoglycaemia—Doxorubicin—breast cancer	0.000176	0.00115	CcSEcCtD
Ethacrynic acid—Vertigo—Paclitaxel—breast cancer	0.000176	0.00115	CcSEcCtD
Ethacrynic acid—Rash—Tamoxifen—breast cancer	0.000175	0.00114	CcSEcCtD
Ethacrynic acid—Dermatitis—Tamoxifen—breast cancer	0.000175	0.00114	CcSEcCtD
Ethacrynic acid—Headache—Tamoxifen—breast cancer	0.000174	0.00113	CcSEcCtD
Ethacrynic acid—Vomiting—Melphalan—breast cancer	0.000173	0.00113	CcSEcCtD
Ethacrynic acid—Tinnitus—Capecitabine—breast cancer	0.000172	0.00112	CcSEcCtD
Ethacrynic acid—Gastrointestinal haemorrhage—Doxorubicin—breast cancer	0.000172	0.00112	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Epirubicin—breast cancer	0.000171	0.00112	CcSEcCtD
Ethacrynic acid—Rash—Melphalan—breast cancer	0.000171	0.00112	CcSEcCtD
Ethacrynic acid—Dermatitis—Melphalan—breast cancer	0.000171	0.00112	CcSEcCtD
Ethacrynic acid—Chills—Docetaxel—breast cancer	0.000171	0.00111	CcSEcCtD
Ethacrynic acid—Asthenia—Vinorelbine—breast cancer	0.00017	0.00111	CcSEcCtD
Ethacrynic acid—Decreased appetite—Irinotecan—breast cancer	0.00017	0.00111	CcSEcCtD
Ethacrynic acid—Decreased appetite—Mitoxantrone—breast cancer	0.00017	0.00111	CcSEcCtD
Ethacrynic acid—Nausea—Vinblastine—breast cancer	0.00017	0.00111	CcSEcCtD
Ethacrynic acid—Convulsion—Paclitaxel—breast cancer	0.000169	0.0011	CcSEcCtD
Ethacrynic acid—Fatigue—Irinotecan—breast cancer	0.000169	0.0011	CcSEcCtD
Ethacrynic acid—Fatigue—Mitoxantrone—breast cancer	0.000169	0.0011	CcSEcCtD
Ethacrynic acid—Vomiting—Goserelin—breast cancer	0.000168	0.0011	CcSEcCtD
Ethacrynic acid—Pain—Mitoxantrone—breast cancer	0.000167	0.00109	CcSEcCtD
Ethacrynic acid—Pain—Irinotecan—breast cancer	0.000167	0.00109	CcSEcCtD
Ethacrynic acid—Rash—Goserelin—breast cancer	0.000167	0.00109	CcSEcCtD
Ethacrynic acid—Dermatitis—Goserelin—breast cancer	0.000167	0.00109	CcSEcCtD
Ethacrynic acid—Headache—Goserelin—breast cancer	0.000166	0.00108	CcSEcCtD
Ethacrynic acid—Anxiety—Paclitaxel—breast cancer	0.000166	0.00108	CcSEcCtD
Ethacrynic acid—Decreased appetite—Gemcitabine—breast cancer	0.000166	0.00108	CcSEcCtD
Ethacrynic acid—Chills—Capecitabine—breast cancer	0.000165	0.00108	CcSEcCtD
Ethacrynic acid—Nausea—Tamoxifen—breast cancer	0.000165	0.00107	CcSEcCtD
Ethacrynic acid—Discomfort—Paclitaxel—breast cancer	0.000164	0.00107	CcSEcCtD
Ethacrynic acid—Abdominal discomfort—Methotrexate—breast cancer	0.000164	0.00107	CcSEcCtD
Ethacrynic acid—Fatigue—Gemcitabine—breast cancer	0.000164	0.00107	CcSEcCtD
Ethacrynic acid—Pain—Gemcitabine—breast cancer	0.000163	0.00106	CcSEcCtD
Ethacrynic acid—Decreased appetite—Fluorouracil—breast cancer	0.000163	0.00106	CcSEcCtD
Ethacrynic acid—Asthenia—Thiotepa—breast cancer	0.000163	0.00106	CcSEcCtD
Ethacrynic acid—Diarrhoea—Vinorelbine—breast cancer	0.000162	0.00106	CcSEcCtD
Ethacrynic acid—Nausea—Melphalan—breast cancer	0.000161	0.00105	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Irinotecan—breast cancer	0.000161	0.00105	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Mitoxantrone—breast cancer	0.000161	0.00105	CcSEcCtD
Ethacrynic acid—Confusional state—Paclitaxel—breast cancer	0.000161	0.00105	CcSEcCtD
Ethacrynic acid—Dysphagia—Epirubicin—breast cancer	0.00016	0.00105	CcSEcCtD
Ethacrynic acid—Neutropenia—Methotrexate—breast cancer	0.00016	0.00105	CcSEcCtD
Ethacrynic acid—Pain—Fluorouracil—breast cancer	0.00016	0.00105	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Doxorubicin—breast cancer	0.000159	0.00103	CcSEcCtD
Ethacrynic acid—Nausea—Goserelin—breast cancer	0.000157	0.00103	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Gemcitabine—breast cancer	0.000157	0.00102	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Paclitaxel—breast cancer	0.000156	0.00102	CcSEcCtD
Ethacrynic acid—Diarrhoea—Thiotepa—breast cancer	0.000155	0.00101	CcSEcCtD
Ethacrynic acid—Body temperature increased—Mitoxantrone—breast cancer	0.000155	0.00101	CcSEcCtD
Ethacrynic acid—Body temperature increased—Irinotecan—breast cancer	0.000155	0.00101	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Fluorouracil—breast cancer	0.000154	0.00101	CcSEcCtD
Ethacrynic acid—Anorexia—Paclitaxel—breast cancer	0.000152	0.000992	CcSEcCtD
Ethacrynic acid—Vision blurred—Capecitabine—breast cancer	0.000151	0.000986	CcSEcCtD
Ethacrynic acid—Vomiting—Vinorelbine—breast cancer	0.000151	0.000984	CcSEcCtD
Ethacrynic acid—Body temperature increased—Gemcitabine—breast cancer	0.000151	0.000983	CcSEcCtD
Ethacrynic acid—Neutropenia—Epirubicin—breast cancer	0.00015	0.000978	CcSEcCtD
Ethacrynic acid—Rash—Vinorelbine—breast cancer	0.00015	0.000976	CcSEcCtD
Ethacrynic acid—Dermatitis—Vinorelbine—breast cancer	0.000149	0.000975	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Capecitabine—breast cancer	0.000149	0.000971	CcSEcCtD
Ethacrynic acid—Headache—Vinorelbine—breast cancer	0.000149	0.000969	CcSEcCtD
Ethacrynic acid—Dysphagia—Doxorubicin—breast cancer	0.000148	0.000968	CcSEcCtD
Ethacrynic acid—Body temperature increased—Fluorouracil—breast cancer	0.000148	0.000966	CcSEcCtD
Ethacrynic acid—Haematuria—Methotrexate—breast cancer	0.000146	0.00095	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Epirubicin—breast cancer	0.000145	0.000944	CcSEcCtD
Ethacrynic acid—Malaise—Capecitabine—breast cancer	0.000145	0.000944	CcSEcCtD
Ethacrynic acid—Vertigo—Capecitabine—breast cancer	0.000144	0.00094	CcSEcCtD
Ethacrynic acid—Vomiting—Thiotepa—breast cancer	0.000144	0.00094	CcSEcCtD
Ethacrynic acid—Convulsion—Docetaxel—breast cancer	0.000144	0.000936	CcSEcCtD
Ethacrynic acid—Rash—Thiotepa—breast cancer	0.000143	0.000932	CcSEcCtD
Ethacrynic acid—Dermatitis—Thiotepa—breast cancer	0.000143	0.000931	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Methotrexate—breast cancer	0.000143	0.00093	CcSEcCtD
Ethacrynic acid—Headache—Thiotepa—breast cancer	0.000142	0.000926	CcSEcCtD
Ethacrynic acid—Nausea—Vinorelbine—breast cancer	0.000141	0.000919	CcSEcCtD
Ethacrynic acid—Asthenia—Mitoxantrone—breast cancer	0.00014	0.000916	CcSEcCtD
Ethacrynic acid—Asthenia—Irinotecan—breast cancer	0.00014	0.000916	CcSEcCtD
Ethacrynic acid—Jaundice—Epirubicin—breast cancer	0.000139	0.000909	CcSEcCtD
Ethacrynic acid—Neutropenia—Doxorubicin—breast cancer	0.000139	0.000905	CcSEcCtD
Ethacrynic acid—Decreased appetite—Paclitaxel—breast cancer	0.000139	0.000905	CcSEcCtD
Ethacrynic acid—Fatigue—Paclitaxel—breast cancer	0.000138	0.000897	CcSEcCtD
Ethacrynic acid—Asthenia—Gemcitabine—breast cancer	0.000137	0.000892	CcSEcCtD
Ethacrynic acid—Pain—Paclitaxel—breast cancer	0.000136	0.00089	CcSEcCtD
Ethacrynic acid—Haematuria—Epirubicin—breast cancer	0.000136	0.00089	CcSEcCtD
Ethacrynic acid—Confusional state—Docetaxel—breast cancer	0.000136	0.000889	CcSEcCtD
Ethacrynic acid—Anxiety—Capecitabine—breast cancer	0.000136	0.000888	CcSEcCtD
Ethacrynic acid—Discomfort—Capecitabine—breast cancer	0.000135	0.00088	CcSEcCtD
Ethacrynic acid—Nausea—Thiotepa—breast cancer	0.000135	0.000878	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Doxorubicin—breast cancer	0.000134	0.000873	CcSEcCtD
Ethacrynic acid—Diarrhoea—Irinotecan—breast cancer	0.000134	0.000873	CcSEcCtD
Ethacrynic acid—Diarrhoea—Mitoxantrone—breast cancer	0.000134	0.000873	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Epirubicin—breast cancer	0.000133	0.000871	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Docetaxel—breast cancer	0.000132	0.000864	CcSEcCtD
Ethacrynic acid—Confusional state—Capecitabine—breast cancer	0.000132	0.000861	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Paclitaxel—breast cancer	0.000131	0.000858	CcSEcCtD
Ethacrynic acid—Diarrhoea—Gemcitabine—breast cancer	0.00013	0.000851	CcSEcCtD
Ethacrynic acid—Jaundice—Doxorubicin—breast cancer	0.000129	0.000841	CcSEcCtD
Ethacrynic acid—Anorexia—Docetaxel—breast cancer	0.000129	0.000841	CcSEcCtD
Ethacrynic acid—Diarrhoea—Fluorouracil—breast cancer	0.000128	0.000836	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Capecitabine—breast cancer	0.000128	0.000836	CcSEcCtD
Ethacrynic acid—Tinnitus—Methotrexate—breast cancer	0.000128	0.000834	CcSEcCtD
Ethacrynic acid—Haematuria—Doxorubicin—breast cancer	0.000126	0.000823	CcSEcCtD
Ethacrynic acid—Body temperature increased—Paclitaxel—breast cancer	0.000126	0.000823	CcSEcCtD
Ethacrynic acid—Anorexia—Capecitabine—breast cancer	0.000125	0.000814	CcSEcCtD
Ethacrynic acid—Vomiting—Irinotecan—breast cancer	0.000124	0.000811	CcSEcCtD
Ethacrynic acid—Vomiting—Mitoxantrone—breast cancer	0.000124	0.000811	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Doxorubicin—breast cancer	0.000123	0.000806	CcSEcCtD
Ethacrynic acid—Rash—Mitoxantrone—breast cancer	0.000123	0.000805	CcSEcCtD
Ethacrynic acid—Rash—Irinotecan—breast cancer	0.000123	0.000805	CcSEcCtD
Ethacrynic acid—Dermatitis—Mitoxantrone—breast cancer	0.000123	0.000804	CcSEcCtD
Ethacrynic acid—Dermatitis—Irinotecan—breast cancer	0.000123	0.000804	CcSEcCtD
Ethacrynic acid—Chills—Methotrexate—breast cancer	0.000123	0.000803	CcSEcCtD
Ethacrynic acid—Headache—Irinotecan—breast cancer	0.000123	0.000799	CcSEcCtD
Ethacrynic acid—Headache—Mitoxantrone—breast cancer	0.000123	0.000799	CcSEcCtD
Ethacrynic acid—Vomiting—Gemcitabine—breast cancer	0.000121	0.00079	CcSEcCtD
Ethacrynic acid—Rash—Gemcitabine—breast cancer	0.00012	0.000784	CcSEcCtD
Ethacrynic acid—Dermatitis—Gemcitabine—breast cancer	0.00012	0.000783	CcSEcCtD
Ethacrynic acid—Tinnitus—Epirubicin—breast cancer	0.00012	0.000781	CcSEcCtD
Ethacrynic acid—Headache—Gemcitabine—breast cancer	0.000119	0.000779	CcSEcCtD
Ethacrynic acid—Vomiting—Fluorouracil—breast cancer	0.000119	0.000777	CcSEcCtD
Ethacrynic acid—Rash—Fluorouracil—breast cancer	0.000118	0.000771	CcSEcCtD
Ethacrynic acid—Dermatitis—Fluorouracil—breast cancer	0.000118	0.00077	CcSEcCtD
Ethacrynic acid—Decreased appetite—Docetaxel—breast cancer	0.000118	0.000767	CcSEcCtD
Ethacrynic acid—Headache—Fluorouracil—breast cancer	0.000117	0.000766	CcSEcCtD
Ethacrynic acid—Fatigue—Docetaxel—breast cancer	0.000117	0.000761	CcSEcCtD
Ethacrynic acid—Nausea—Mitoxantrone—breast cancer	0.000116	0.000758	CcSEcCtD
Ethacrynic acid—Nausea—Irinotecan—breast cancer	0.000116	0.000758	CcSEcCtD
Ethacrynic acid—Pain—Docetaxel—breast cancer	0.000116	0.000754	CcSEcCtD
Ethacrynic acid—Chills—Epirubicin—breast cancer	0.000115	0.000751	CcSEcCtD
Ethacrynic acid—Asthenia—Paclitaxel—breast cancer	0.000114	0.000747	CcSEcCtD
Ethacrynic acid—Decreased appetite—Capecitabine—breast cancer	0.000114	0.000742	CcSEcCtD
Ethacrynic acid—Nausea—Gemcitabine—breast cancer	0.000113	0.000738	CcSEcCtD
Ethacrynic acid—Fatigue—Capecitabine—breast cancer	0.000113	0.000736	CcSEcCtD
Ethacrynic acid—Vision blurred—Methotrexate—breast cancer	0.000113	0.000734	CcSEcCtD
Ethacrynic acid—Pain—Capecitabine—breast cancer	0.000112	0.00073	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Docetaxel—breast cancer	0.000111	0.000727	CcSEcCtD
Ethacrynic acid—Nausea—Fluorouracil—breast cancer	0.000111	0.000726	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Methotrexate—breast cancer	0.000111	0.000723	CcSEcCtD
Ethacrynic acid—Tinnitus—Doxorubicin—breast cancer	0.000111	0.000723	CcSEcCtD
Ethacrynic acid—Diarrhoea—Paclitaxel—breast cancer	0.000109	0.000712	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Capecitabine—breast cancer	0.000108	0.000704	CcSEcCtD
Ethacrynic acid—Malaise—Methotrexate—breast cancer	0.000108	0.000703	CcSEcCtD
Ethacrynic acid—Vertigo—Methotrexate—breast cancer	0.000107	0.0007	CcSEcCtD
Ethacrynic acid—Body temperature increased—Docetaxel—breast cancer	0.000107	0.000697	CcSEcCtD
Ethacrynic acid—Chills—Doxorubicin—breast cancer	0.000107	0.000695	CcSEcCtD
Ethacrynic acid—Vision blurred—Epirubicin—breast cancer	0.000105	0.000687	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Epirubicin—breast cancer	0.000104	0.000676	CcSEcCtD
Ethacrynic acid—Body temperature increased—Capecitabine—breast cancer	0.000104	0.000675	CcSEcCtD
Ethacrynic acid—Convulsion—Methotrexate—breast cancer	0.000103	0.000675	CcSEcCtD
Ethacrynic acid—Vomiting—Paclitaxel—breast cancer	0.000101	0.000662	CcSEcCtD
Ethacrynic acid—Malaise—Epirubicin—breast cancer	0.000101	0.000657	CcSEcCtD
Ethacrynic acid—Rash—Paclitaxel—breast cancer	0.000101	0.000656	CcSEcCtD
Ethacrynic acid—Dermatitis—Paclitaxel—breast cancer	0.000101	0.000656	CcSEcCtD
Ethacrynic acid—Discomfort—Methotrexate—breast cancer	0.0001	0.000655	CcSEcCtD
Ethacrynic acid—Vertigo—Epirubicin—breast cancer	0.0001	0.000655	CcSEcCtD
Ethacrynic acid—Headache—Paclitaxel—breast cancer	9.99e-05	0.000652	CcSEcCtD
Ethacrynic acid—Confusional state—Methotrexate—breast cancer	9.83e-05	0.000641	CcSEcCtD
Ethacrynic acid—Vision blurred—Doxorubicin—breast cancer	9.75e-05	0.000636	CcSEcCtD
Ethacrynic acid—Asthenia—Docetaxel—breast cancer	9.7e-05	0.000633	CcSEcCtD
Ethacrynic acid—Convulsion—Epirubicin—breast cancer	9.68e-05	0.000632	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Doxorubicin—breast cancer	9.59e-05	0.000626	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Methotrexate—breast cancer	9.54e-05	0.000623	CcSEcCtD
Ethacrynic acid—Anxiety—Epirubicin—breast cancer	9.48e-05	0.000619	CcSEcCtD
Ethacrynic acid—Nausea—Paclitaxel—breast cancer	9.48e-05	0.000618	CcSEcCtD
Ethacrynic acid—Discomfort—Epirubicin—breast cancer	9.4e-05	0.000613	CcSEcCtD
Ethacrynic acid—Asthenia—Capecitabine—breast cancer	9.39e-05	0.000613	CcSEcCtD
Ethacrynic acid—Malaise—Doxorubicin—breast cancer	9.33e-05	0.000608	CcSEcCtD
Ethacrynic acid—Vertigo—Doxorubicin—breast cancer	9.29e-05	0.000606	CcSEcCtD
Ethacrynic acid—Anorexia—Methotrexate—breast cancer	9.29e-05	0.000606	CcSEcCtD
Ethacrynic acid—Diarrhoea—Docetaxel—breast cancer	9.25e-05	0.000604	CcSEcCtD
Ethacrynic acid—Confusional state—Epirubicin—breast cancer	9.2e-05	0.0006	CcSEcCtD
Ethacrynic acid—Convulsion—Doxorubicin—breast cancer	8.96e-05	0.000584	CcSEcCtD
Ethacrynic acid—Diarrhoea—Capecitabine—breast cancer	8.96e-05	0.000584	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Epirubicin—breast cancer	8.93e-05	0.000583	CcSEcCtD
Ethacrynic acid—Anxiety—Doxorubicin—breast cancer	8.77e-05	0.000572	CcSEcCtD
Ethacrynic acid—Discomfort—Doxorubicin—breast cancer	8.7e-05	0.000567	CcSEcCtD
Ethacrynic acid—Anorexia—Epirubicin—breast cancer	8.69e-05	0.000567	CcSEcCtD
Ethacrynic acid—Vomiting—Docetaxel—breast cancer	8.6e-05	0.000561	CcSEcCtD
Ethacrynic acid—Rash—Docetaxel—breast cancer	8.53e-05	0.000556	CcSEcCtD
Ethacrynic acid—Dermatitis—Docetaxel—breast cancer	8.52e-05	0.000556	CcSEcCtD
Ethacrynic acid—Confusional state—Doxorubicin—breast cancer	8.51e-05	0.000555	CcSEcCtD
Ethacrynic acid—Decreased appetite—Methotrexate—breast cancer	8.47e-05	0.000553	CcSEcCtD
Ethacrynic acid—Headache—Docetaxel—breast cancer	8.47e-05	0.000553	CcSEcCtD
Ethacrynic acid—Fatigue—Methotrexate—breast cancer	8.4e-05	0.000548	CcSEcCtD
Ethacrynic acid—Pain—Methotrexate—breast cancer	8.33e-05	0.000544	CcSEcCtD
Ethacrynic acid—Vomiting—Capecitabine—breast cancer	8.32e-05	0.000543	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Doxorubicin—breast cancer	8.26e-05	0.000539	CcSEcCtD
Ethacrynic acid—Rash—Capecitabine—breast cancer	8.26e-05	0.000539	CcSEcCtD
Ethacrynic acid—Dermatitis—Capecitabine—breast cancer	8.25e-05	0.000538	CcSEcCtD
Ethacrynic acid—Headache—Capecitabine—breast cancer	8.2e-05	0.000535	CcSEcCtD
Ethacrynic acid—Anorexia—Doxorubicin—breast cancer	8.04e-05	0.000525	CcSEcCtD
Ethacrynic acid—Nausea—Docetaxel—breast cancer	8.03e-05	0.000524	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Methotrexate—breast cancer	8.03e-05	0.000524	CcSEcCtD
Ethacrynic acid—Decreased appetite—Epirubicin—breast cancer	7.93e-05	0.000517	CcSEcCtD
Ethacrynic acid—Fatigue—Epirubicin—breast cancer	7.86e-05	0.000513	CcSEcCtD
Ethacrynic acid—Pain—Epirubicin—breast cancer	7.8e-05	0.000509	CcSEcCtD
Ethacrynic acid—Nausea—Capecitabine—breast cancer	7.78e-05	0.000507	CcSEcCtD
Ethacrynic acid—Body temperature increased—Methotrexate—breast cancer	7.7e-05	0.000503	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Epirubicin—breast cancer	7.52e-05	0.00049	CcSEcCtD
Ethacrynic acid—Decreased appetite—Doxorubicin—breast cancer	7.34e-05	0.000479	CcSEcCtD
Ethacrynic acid—Fatigue—Doxorubicin—breast cancer	7.28e-05	0.000475	CcSEcCtD
Ethacrynic acid—Pain—Doxorubicin—breast cancer	7.22e-05	0.000471	CcSEcCtD
Ethacrynic acid—Body temperature increased—Epirubicin—breast cancer	7.21e-05	0.00047	CcSEcCtD
Ethacrynic acid—Asthenia—Methotrexate—breast cancer	6.99e-05	0.000456	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Doxorubicin—breast cancer	6.95e-05	0.000454	CcSEcCtD
Ethacrynic acid—Body temperature increased—Doxorubicin—breast cancer	6.67e-05	0.000435	CcSEcCtD
Ethacrynic acid—Diarrhoea—Methotrexate—breast cancer	6.67e-05	0.000435	CcSEcCtD
Ethacrynic acid—Asthenia—Epirubicin—breast cancer	6.54e-05	0.000427	CcSEcCtD
Ethacrynic acid—Diarrhoea—Epirubicin—breast cancer	6.24e-05	0.000407	CcSEcCtD
Ethacrynic acid—Vomiting—Methotrexate—breast cancer	6.2e-05	0.000404	CcSEcCtD
Ethacrynic acid—Rash—Methotrexate—breast cancer	6.15e-05	0.000401	CcSEcCtD
Ethacrynic acid—Dermatitis—Methotrexate—breast cancer	6.14e-05	0.000401	CcSEcCtD
Ethacrynic acid—Headache—Methotrexate—breast cancer	6.11e-05	0.000398	CcSEcCtD
Ethacrynic acid—Asthenia—Doxorubicin—breast cancer	6.06e-05	0.000395	CcSEcCtD
Ethacrynic acid—Vomiting—Epirubicin—breast cancer	5.8e-05	0.000378	CcSEcCtD
Ethacrynic acid—Nausea—Methotrexate—breast cancer	5.79e-05	0.000378	CcSEcCtD
Ethacrynic acid—Diarrhoea—Doxorubicin—breast cancer	5.77e-05	0.000377	CcSEcCtD
Ethacrynic acid—Rash—Epirubicin—breast cancer	5.75e-05	0.000375	CcSEcCtD
Ethacrynic acid—Dermatitis—Epirubicin—breast cancer	5.75e-05	0.000375	CcSEcCtD
Ethacrynic acid—Headache—Epirubicin—breast cancer	5.71e-05	0.000373	CcSEcCtD
Ethacrynic acid—Nausea—Epirubicin—breast cancer	5.42e-05	0.000353	CcSEcCtD
Ethacrynic acid—Vomiting—Doxorubicin—breast cancer	5.37e-05	0.00035	CcSEcCtD
Ethacrynic acid—Rash—Doxorubicin—breast cancer	5.32e-05	0.000347	CcSEcCtD
Ethacrynic acid—Dermatitis—Doxorubicin—breast cancer	5.32e-05	0.000347	CcSEcCtD
Ethacrynic acid—Headache—Doxorubicin—breast cancer	5.29e-05	0.000345	CcSEcCtD
Ethacrynic acid—Nausea—Doxorubicin—breast cancer	5.01e-05	0.000327	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—CYP3A4—breast cancer	3.6e-05	0.000357	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—NCOA2—breast cancer	3.58e-05	0.000355	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—RELA—breast cancer	3.57e-05	0.000354	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CYP1B1—breast cancer	3.54e-05	0.000351	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—FHL2—breast cancer	3.54e-05	0.000351	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—RAF1—breast cancer	3.52e-05	0.000349	CbGpPWpGaD
Ethacrynic acid—ALB—SLC-mediated transmembrane transport—SLC5A5—breast cancer	3.49e-05	0.000346	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—HSP90AA1—breast cancer	3.47e-05	0.000344	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—PTGS2—breast cancer	3.47e-05	0.000343	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PLG—breast cancer	3.43e-05	0.000339	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—SLC5A5—breast cancer	3.42e-05	0.000338	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—F3—breast cancer	3.4e-05	0.000337	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—NCOA1—breast cancer	3.38e-05	0.000335	CbGpPWpGaD
Ethacrynic acid—ALB—SLC-mediated transmembrane transport—SLC2A1—breast cancer	3.37e-05	0.000334	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ATP7B—breast cancer	3.37e-05	0.000333	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—STK11—breast cancer	3.33e-05	0.00033	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CYP19A1—breast cancer	3.33e-05	0.00033	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—SLC2A1—breast cancer	3.3e-05	0.000327	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	3.29e-05	0.000326	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PDGFA—breast cancer	3.25e-05	0.000322	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—IL1B—breast cancer	3.23e-05	0.00032	CbGpPWpGaD
Ethacrynic acid—SLC22A6—SLC-mediated transmembrane transport—ALB—breast cancer	3.21e-05	0.000317	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	3.19e-05	0.000316	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—ITPR1—breast cancer	3.15e-05	0.000312	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ABCC1—breast cancer	3.13e-05	0.00031	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—COMT—breast cancer	3.1e-05	0.000307	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GSTP1—breast cancer	3.08e-05	0.000305	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—HMOX1—breast cancer	3.04e-05	0.000301	CbGpPWpGaD
Ethacrynic acid—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—breast cancer	3.04e-05	0.000301	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ITPR1—breast cancer	3.03e-05	0.0003	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—NCOA1—breast cancer	3.02e-05	0.000299	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet degranulation—VEGFA—breast cancer	2.95e-05	0.000292	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—TNF—breast cancer	2.95e-05	0.000292	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—HGF—breast cancer	2.95e-05	0.000292	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PLA2G4A—breast cancer	2.95e-05	0.000292	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—PLG—breast cancer	2.94e-05	0.000291	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—GPX2—breast cancer	2.93e-05	0.00029	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—IL6—breast cancer	2.92e-05	0.00029	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ABCB1—breast cancer	2.92e-05	0.000289	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—CSF2—breast cancer	2.91e-05	0.000288	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—GPX4—breast cancer	2.9e-05	0.000287	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—TYMS—breast cancer	2.86e-05	0.000284	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—CFL1—breast cancer	2.84e-05	0.000281	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PLA2G4A—breast cancer	2.83e-05	0.00028	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—NCOR1—breast cancer	2.83e-05	0.00028	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GSTM1—breast cancer	2.83e-05	0.00028	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—IDH1—breast cancer	2.83e-05	0.00028	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—GRB7—breast cancer	2.81e-05	0.000278	CbGpPWpGaD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—breast cancer	2.81e-05	0.000278	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SYNJ2—breast cancer	2.75e-05	0.000272	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—HMOX1—breast cancer	2.71e-05	0.000269	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GPX1—breast cancer	2.71e-05	0.000268	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet degranulation—TGFB1—breast cancer	2.71e-05	0.000268	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CYP1A1—breast cancer	2.68e-05	0.000266	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ERCC2—breast cancer	2.66e-05	0.000264	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—TUBB3—breast cancer	2.66e-05	0.000264	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—VEGFC—breast cancer	2.65e-05	0.000263	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—ALDOA—breast cancer	2.65e-05	0.000263	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ABCB1—breast cancer	2.6e-05	0.000258	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—TP53—breast cancer	2.6e-05	0.000257	CbGpPWpGaD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—breast cancer	2.58e-05	0.000255	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NDUFS3—breast cancer	2.55e-05	0.000253	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—MTHFR—breast cancer	2.5e-05	0.000248	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—MED12—breast cancer	2.45e-05	0.000243	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CHST9—breast cancer	2.4e-05	0.000238	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—IL6—breast cancer	2.38e-05	0.000236	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	2.35e-05	0.000232	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—TNF—breast cancer	2.34e-05	0.000232	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CAV1—breast cancer	2.31e-05	0.000229	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—FN1—breast cancer	2.29e-05	0.000226	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	2.28e-05	0.000226	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—COX11—breast cancer	2.27e-05	0.000225	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	2.24e-05	0.000222	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—TGFB2—breast cancer	2.23e-05	0.000221	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—THBS1—breast cancer	2.22e-05	0.00022	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC2A2—breast cancer	2.21e-05	0.000219	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—GATA3—breast cancer	2.19e-05	0.000217	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PIK3CG—breast cancer	2.19e-05	0.000217	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—ACHE—breast cancer	2.17e-05	0.000215	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ABCG2—breast cancer	2.17e-05	0.000215	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—EGF—breast cancer	2.16e-05	0.000214	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PIK3CG—breast cancer	2.1e-05	0.000208	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SHMT1—breast cancer	2.08e-05	0.000206	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CDA—breast cancer	2.08e-05	0.000206	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	2.05e-05	0.000203	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	2.03e-05	0.000201	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SLC2A5—breast cancer	2e-05	0.000198	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SLCO1B1—breast cancer	2e-05	0.000198	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—IGF1—breast cancer	2e-05	0.000198	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—AKT2—breast cancer	2e-05	0.000198	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IFNB1—breast cancer	1.97e-05	0.000195	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	1.96e-05	0.000194	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—APRT—breast cancer	1.93e-05	0.000192	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—TFRC—breast cancer	1.93e-05	0.000191	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PIK3CD—breast cancer	1.92e-05	0.00019	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—SERPINE1—breast cancer	1.9e-05	0.000188	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—FASN—breast cancer	1.9e-05	0.000188	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—BCHE—breast cancer	1.89e-05	0.000187	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—IL6—breast cancer	1.89e-05	0.000187	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—NCOA2—breast cancer	1.86e-05	0.000184	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PIK3CD—breast cancer	1.85e-05	0.000183	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ALB—breast cancer	1.82e-05	0.000181	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ESRRA—breast cancer	1.82e-05	0.00018	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ANGPTL4—breast cancer	1.82e-05	0.00018	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PLAUR—breast cancer	1.81e-05	0.000179	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC5A5—breast cancer	1.78e-05	0.000176	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PLG—breast cancer	1.77e-05	0.000175	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—NOS3—breast cancer	1.75e-05	0.000173	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	1.73e-05	0.000171	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HADHB—breast cancer	1.72e-05	0.000171	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GPI—breast cancer	1.72e-05	0.000171	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—RAF1—breast cancer	1.72e-05	0.00017	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC2A1—breast cancer	1.71e-05	0.00017	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PDGFA—breast cancer	1.68e-05	0.000166	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PIK3CB—breast cancer	1.68e-05	0.000166	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	1.65e-05	0.000163	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ALDH7A1—breast cancer	1.64e-05	0.000163	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ALDH1A1—breast cancer	1.64e-05	0.000163	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ALB—breast cancer	1.63e-05	0.000161	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—ITPR1—breast cancer	1.63e-05	0.000161	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	1.63e-05	0.000161	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—ABL1—breast cancer	1.61e-05	0.00016	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PIK3CB—breast cancer	1.61e-05	0.00016	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PTGS2—breast cancer	1.6e-05	0.000158	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—FHL2—breast cancer	1.58e-05	0.000156	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PHGDH—breast cancer	1.58e-05	0.000156	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NME1—breast cancer	1.58e-05	0.000156	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—UMPS—breast cancer	1.58e-05	0.000156	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ADSL—breast cancer	1.58e-05	0.000156	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—NCOA1—breast cancer	1.57e-05	0.000155	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—BRIP1—breast cancer	1.55e-05	0.000153	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—LDHB—breast cancer	1.55e-05	0.000153	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HPSE—breast cancer	1.55e-05	0.000153	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—IL2—breast cancer	1.54e-05	0.000152	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—PLG—breast cancer	1.53e-05	0.000151	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—HGF—breast cancer	1.52e-05	0.00015	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PLA2G4A—breast cancer	1.52e-05	0.00015	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—CSF2—breast cancer	1.5e-05	0.000149	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—RAF1—breast cancer	1.47e-05	0.000146	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTA3—breast cancer	1.47e-05	0.000145	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ABCC1—breast cancer	1.47e-05	0.000145	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HMMR—breast cancer	1.47e-05	0.000145	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PPARGC1B—breast cancer	1.42e-05	0.000141	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—HMOX1—breast cancer	1.41e-05	0.00014	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PTEN—breast cancer	1.39e-05	0.000138	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.38e-05	0.000137	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.38e-05	0.000137	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ABCB1—breast cancer	1.35e-05	0.000134	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—SRC—breast cancer	1.34e-05	0.000133	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTA4—breast cancer	1.34e-05	0.000133	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CA9—breast cancer	1.34e-05	0.000133	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.32e-05	0.000131	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.31e-05	0.00013	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—VEGFA—breast cancer	1.31e-05	0.00013	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GPX2—breast cancer	1.31e-05	0.000129	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTA2—breast cancer	1.31e-05	0.000129	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—MMP1—breast cancer	1.29e-05	0.000128	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GPX4—breast cancer	1.29e-05	0.000128	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SULT1A1—breast cancer	1.29e-05	0.000128	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—CDK2—breast cancer	1.27e-05	0.000125	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PLAU—breast cancer	1.27e-05	0.000125	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTA1—breast cancer	1.26e-05	0.000125	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—IDH1—breast cancer	1.26e-05	0.000125	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NAT2—breast cancer	1.25e-05	0.000123	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—CAV1—breast cancer	1.24e-05	0.000123	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—MAPK3—breast cancer	1.24e-05	0.000123	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—TGFB1—breast cancer	1.2e-05	0.000119	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—FN1—breast cancer	1.18e-05	0.000117	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—NOS2—breast cancer	1.16e-05	0.000115	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PIK3CG—breast cancer	1.13e-05	0.000112	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.13e-05	0.000112	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—EGF—breast cancer	1.11e-05	0.00011	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—MED12—breast cancer	1.09e-05	0.000108	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—DPYD—breast cancer	1.09e-05	0.000108	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ALDOA—breast cancer	1.08e-05	0.000107	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NCOA3—breast cancer	1.04e-05	0.000103	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SLC2A2—breast cancer	1.04e-05	0.000103	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IGF1—breast cancer	1.03e-05	0.000102	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—AKT2—breast cancer	1.03e-05	0.000102	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.03e-05	0.000102	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PIK3CA—breast cancer	1.02e-05	0.000101	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ABCG2—breast cancer	1.02e-05	0.000101	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CPT1A—breast cancer	1.02e-05	0.000101	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—MTR—breast cancer	1.02e-05	0.000101	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HPGDS—breast cancer	9.96e-06	9.87e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PIK3CD—breast cancer	9.91e-06	9.81e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HBA1—breast cancer	9.9e-06	9.8e-05	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PIK3CA—breast cancer	9.82e-06	9.72e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—SERPINE1—breast cancer	9.8e-06	9.71e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ACHE—breast cancer	9.66e-06	9.57e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTT1—breast cancer	9.66e-06	9.57e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—NOS3—breast cancer	9.36e-06	9.27e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP17A1—breast cancer	9.15e-06	9.06e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PTGS1—breast cancer	9.06e-06	8.97e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ENO1—breast cancer	9.06e-06	8.97e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	9.02e-06	8.93e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP2D6—breast cancer	8.88e-06	8.79e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—RAF1—breast cancer	8.85e-06	8.76e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NCOA2—breast cancer	8.72e-06	8.63e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PIK3CB—breast cancer	8.64e-06	8.55e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—FASN—breast cancer	8.45e-06	8.37e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—BCHE—breast cancer	8.42e-06	8.34e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—AKT1—breast cancer	8.35e-06	8.26e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SLC5A5—breast cancer	8.32e-06	8.23e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NQO1—breast cancer	8.03e-06	7.95e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SLC2A1—breast cancer	8.03e-06	7.95e-05	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—AKT1—breast cancer	8.02e-06	7.94e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IL2—breast cancer	7.93e-06	7.86e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	7.86e-06	7.79e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP3A4—breast cancer	7.83e-06	7.76e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	7.79e-06	7.72e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP1B1—breast cancer	7.7e-06	7.62e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—RAF1—breast cancer	7.66e-06	7.58e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HSP90AA1—breast cancer	7.55e-06	7.48e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NCOA1—breast cancer	7.35e-06	7.27e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—STK11—breast cancer	7.24e-06	7.17e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP19A1—breast cancer	7.24e-06	7.17e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—SRC—breast cancer	6.92e-06	6.85e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	6.8e-06	6.73e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—VEGFA—breast cancer	6.74e-06	6.68e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—COMT—breast cancer	6.73e-06	6.66e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTP1—breast cancer	6.7e-06	6.63e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HMOX1—breast cancer	6.61e-06	6.54e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ITPR1—breast cancer	6.59e-06	6.53e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—MAPK3—breast cancer	6.38e-06	6.32e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ABCB1—breast cancer	6.34e-06	6.28e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—TYMS—breast cancer	6.23e-06	6.17e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—TGFB1—breast cancer	6.19e-06	6.13e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NCOR1—breast cancer	6.16e-06	6.1e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PLA2G4A—breast cancer	6.16e-06	6.1e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTM1—breast cancer	6.16e-06	6.1e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GPX1—breast cancer	5.9e-06	5.84e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP1A1—breast cancer	5.84e-06	5.78e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ERCC2—breast cancer	5.79e-06	5.73e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—KRAS—breast cancer	5.73e-06	5.68e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—MTHFR—breast cancer	5.44e-06	5.39e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PIK3CA—breast cancer	5.27e-06	5.21e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—TP53—breast cancer	5.09e-06	5.04e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CAV1—breast cancer	5.02e-06	4.97e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—HRAS—breast cancer	4.87e-06	4.82e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.79e-06	4.75e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PIK3CG—breast cancer	4.57e-06	4.53e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—AKT1—breast cancer	4.3e-06	4.26e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PIK3CD—breast cancer	4.02e-06	3.98e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NOS3—breast cancer	3.79e-06	3.76e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PIK3CB—breast cancer	3.5e-06	3.47e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PTGS2—breast cancer	3.47e-06	3.44e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PTEN—breast cancer	3.03e-06	3e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PIK3CA—breast cancer	2.14e-06	2.11e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—AKT1—breast cancer	1.74e-06	1.73e-05	CbGpPWpGaD
